NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparison of Methods for MicroRNA Isolation from Extracellular Vesicles Obtained from Ascitic Fluids.

Author(s): Skryabin GO, Vinokurova SV, Elkina NV, Denisova DA, Beliaeva AA, Zhordania KI, Bagrov DV, Enikeev AD, Galetsky SA, Komelkov AV, Krasnoshekova GI, Tchevkina EM

Publication: Biochemistry (Mosc), 2022, Vol. 87, Page 1354-1366

PubMed ID: 36509726 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare the yield and percentage of miRNA, small RNA concentration, next generation sequencing results, and levels of individual miRNA among RNA extracts obtained using six different isolation methods from ascites fluid extracellular vesicles (EVs).

Conclusion of Paper

The isolated EVs were of the expected size (118-158 nm) and morphology, and had high levels of the three exosomal proteins.  In the first extraction kit comparison, the Total Exosome RNA & Protein Isolation Kit with column 1 followed by column 2 yielded the most miRNA; but when miRNAeasy Advanced was added in the second comparison the Total Exosome RNA & Protein Isolation Kit with column 1 yielded less miRNA. There were no significant differences in the percentage of miRNA or the concentration of small RNA among the kits in either comparison.  The quantification cycle (Cq) values for individual miRNAs were comparable or higher when extraction was with miRNeasy advanced rather than Total Exosome RNA & Protein Isolation Kit with column 1.  The majority of reads mapped to long non-coding RNA (lncRNA) (31-39%) or mRNAs (22-32%), regardless of extraction method. The percentages of rRNA (5-19%), miRNA (1-10%), and miscellaneous RNA were variable among the kits compared (PureLink, miRNeasy and Total Exosome RNA & Protein Isolation Kit with column 1), with the highest percentage of reads mapping to miRNA isolated using the Total Exosome RNA & Protein Isolation Kit with column 1.

Studies

  1. Study Purpose

    The purpose of this study was to compare the yield and percentage of miRNA, small RNA concentration, next generation sequencing results and levels of individual miRNA among RNA extracts obtained using six different isolation methods from ascites fluid extracellular vesicles (EVs). Within 1 h of collection, ascites fluid from six patients with ovarian cancer was sequentially centrifuged at 4°C for 15 min at 300 g, 20 min at 800 g, 30 min at 2000 g and 30 min at 10,000 g to remove cells and debris. The supernatant was then stored at -80°C until small EV isolation by ultracentrifugation (110,000 g for 3 h followed by recentrifugation of aliquots of the resuspended pellet at 110,000 g for 1 h). The EV pellet was then resuspended in PBS or PureLink Binding buffer (for PureLink RNA extraction) and EVs were quantified by nanoparticle tracking analysis and morphology was evaluated by transmission electron microscopy. The protein expression of isolated EVs was investigated by Western Blotting using antibodies against Flotillin-2, CD9, TSG-101 and PCNA.  miRNAs were extracted from EVs using the Total Exosome RNA & Protein Isolation Kit with both one and two columns, miRNeasy Serum/ Plasma Kit, PureLink miRNA Isolation Kit, and the miRNeasy Advanced Serum/Plasma Kit. Small RNAs were quantified using the Qubit microRNA Assay Kit and size distribution was evaluated by bioanalyzer. Sequencing libraries were constructed using NEBNext Multiplex Small RNA Library Prep Set and single-end sequenced on a HiSeq1500 instrument. Levels of miR-1246, miR-200b, miR-23a, and miR-200c were quantified by real-time RT-PCR.

    Summary of Findings:

    The mean size of the isolated EVs varied from 118-158 nm. The ascites EVs had the proper deflated ball morphology, had high levels of the three exosomal proteins investigated (CD9, Flotillin-2 and TSG-101) and lacked detectable PCNA (the cell-derived marker).  When the PureLink miRNA Isolation Kit (PBS and binding buffer EVs), miRNeasy Serum/Plasma Kit and the Total Exosome RNA & Protein Isolation Kit with column 1 or 2 were compared, the highest miRNA concentration (Bioanalyzer) was achieved using the Total Exosome RNA & Protein Isolation Kit with column 1 followed by the Total Exosome RNA & Protein Isolation Kit with column 2, while the lowest yield was achieved using the PureLink Kit regardless of whether the EVs were in PBS or Binding buffer. Although, the yield from all three specimens was significantly lower using column 2 rather than column 1 when determined by bioanalyzer (P<0.05), when analyzed using the Qubit assay yields were comparable using column 1 and column 2 with the total Exosome RNA & Protein Isolation Kit.  Although there were no significant differences in the percentage miRNAs among the kits (PureLink-PBS, miRNeasy, and Total Exosome RNA & Protein Isolation Kit with column 1), the percentage was highest when the Total Exosome RNA & Protein Isolation Kit with column 2 was used for all three specimens evaluated. When the miRNeasy Serum/Plasma Kit, miRNeasy Advanced Serum/Plasma Kit, and Total Exosome RNA & Protein Isolation Kit with column 1 were compared, the miRNeasy Advanced Kit yielded the most miRNA, although the percentage of miRNA and the concentration of small RNA were comparable among the three kits. Further, the Cq values for individual miRNAs were comparable or higher when extraction was with miRNeasy Advanced rather than Total Exosome RNA & Protein Isolation Kit with column 1.  The majority of reads mapped to lncRNAs (31-39%) or mRNAs (22-32%), regardless of extraction method. The rRNAs (5-19%), miRNAs (1-10%), and miscellaneous RNAs percentages were variable among the kits examined, with the highest percentage of reads that mapped to miRNA achieved using the Total Exosome RNA & Protein Isolation Kit with column 1. While 68.4% of miRNA detected were quantified in RNA extracted from all kits (Total Exosome RNA & Protein Isolation Kit with column 1, miRNeasy and PureLink), an additional 7.7%, 7.7%, and 10.3% of miRNA were only detected in extracts from the miRNeasy, PureLink and Total Exosome RNA & Protein Isolation Kit with column 1, respectively.

     

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA Next generation sequencing
    RNA Fluorometry
    RNA Automated electrophoresis/Bioanalyzer
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Real-time qRT-PCR Specific Targeted nucleic acid miR-1246
    miR-200b
    miR-23a
    miR-200c
    Analyte Extraction and Purification Analyte isolation method Total Exosome RNA & Protein Isolation Kit with column 1
    Total Exosome RNA & Protein Isolation Kit with column 2
    miRNeasy Serum/Plasma Kit
    miRNeasy Advanced
    PureLink from EVs in binding buffer
    PureLink from EVs in PBS

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...